Revance
Revance is a Tennessee-based biotechnology company that researches and develops neuromodulators for the treatment of dermatological disorders.
Business Model:
Revenue: $108.6M
Employees: 201-500
Industries / Tags:
Detailed Revance Information
Geographic Data
Address: 1222 Demonbreun Street
City: Nashville
State: TN
Zip: 37203
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$300M
Raised Total:$1B
Social
Metrics
1,998,948Website Global Rank
10,425Website Monthly Traffic
Twitter Followers
Description
Revance is a Tennessee-based biotechnology company that researches and develops neuromodulators for the treatment of dermatological disorders.
Contact Phone:
+15107423400
Contact Email:
Revance went public on 2/7/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/7/2014
IPO Valuation:
$284M
Ticker Symbol:
RVNC
IPO Price:
$16/share
Amount Raised:
$96M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2020 | HintMD |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
